Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
hepatitis b vaccine (recombinant) (Recombivax) (1 trial)
glycerol phenylbutyrate (ravicti) (1 trial)
levocarnitine (carnitor) (1 trial)
ubiquinone (1 trial)
enoxacin (penetrex) (1 trial)
glatiramer acetate (copaxone) (1 trial)
human fecal microbiota (Reybota) (7 trials)
carfilzomib (kyprolis) (1 trial)
cyclosporine (sandimmune) (1 trial)
dexamethasone (1 trial)
wst11 (1 trial)
agar (1 trial)
autologous fecal microbiota (1 trial)
cetuximab (erbitux) (1 trial)
ciprofloxacin (cipro) (2 trials)
fiber (1 trial)
metformin (glucophage) (1 trial)
methylphenidate (ritalin) (1 trial)
metronidazole (flagyl) (2 trials)
oxygen (1 trial)
pegph20 (1 trial)
vaginal microbiome (1 trial)
Deglutition Disorders (Phase 1)
Dermatitis (Phase 1)
Dermatitis, Atopic (Phase 1)
Eczema (Phase 1)
Hepatitis B (Phase 4)
Myelodysplastic Syndromes (Phase 3)
Preleukemia (Phase 3)
Syndrome (Phase 3)
Trials (21 total)
Trial APIs (22 total)